138 related articles for article (PubMed ID: 28964882)
1. The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics.
Udy AA; Roberts JA; Lipman J; Blot S
Adv Drug Deliv Rev; 2018 Jan; 123():65-74. PubMed ID: 28964882
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
[TBL] [Abstract][Full Text] [Related]
3. [Personalised antibiotic therapy in a surgical intensive care unit overview of current knowledge and the results of an observational kinetic study].
Kaška M; Martinková J; Havel E; Kočí J; Fousková A; Solichová D; Kujovská L; Selke-Krulichová I; Práznovec I; Salavec V
Rozhl Chir; 2014 Sep; 93(9):456-62. PubMed ID: 25301344
[TBL] [Abstract][Full Text] [Related]
4. Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review.
Steele AN; Grimsrud KN; Sen S; Palmieri TL; Greenhalgh DG; Tran NK
J Burn Care Res; 2015; 36(3):e194-211. PubMed ID: 25942648
[TBL] [Abstract][Full Text] [Related]
5. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.
Blanchet B; Jullien V; Vinsonneau C; Tod M
Clin Pharmacokinet; 2008; 47(10):635-54. PubMed ID: 18783295
[TBL] [Abstract][Full Text] [Related]
6. What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review.
Parker S; Lipman J; Koulenti D; Dimopoulos G; Roberts JA
Int J Antimicrob Agents; 2013 Oct; 42(4):289-93. PubMed ID: 23880170
[TBL] [Abstract][Full Text] [Related]
7. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
Roberts JA; Lipman J
Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of systemically administered antibiotics in patients with thermal injury.
Boucher BA; Kuhl DA; Hickerson WL
Clin Infect Dis; 1992 Feb; 14(2):458-63. PubMed ID: 1554831
[TBL] [Abstract][Full Text] [Related]
9. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin pharmacokinetics in patients with severe burn injuries.
Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
[TBL] [Abstract][Full Text] [Related]
11. Infections in critically ill burn patients.
Hidalgo F; Mas D; Rubio M; Garcia-Hierro P
Med Intensiva; 2016 Apr; 40(3):179-85. PubMed ID: 27013315
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic issues for antibiotics in the critically ill patient.
Roberts JA; Lipman J
Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
[TBL] [Abstract][Full Text] [Related]
13. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.
Jamal JA; Economou CJ; Lipman J; Roberts JA
Curr Opin Crit Care; 2012 Oct; 18(5):460-71. PubMed ID: 22820155
[TBL] [Abstract][Full Text] [Related]
14. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Yang RH; Rong XZ; Hua R; Zhang T
Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients.
Pruskowski KA
Surg Infect (Larchmt); 2021 Feb; 22(1):77-82. PubMed ID: 33164665
[No Abstract] [Full Text] [Related]
17. Amikacin population pharmacokinetics among paediatric burn patients.
Sherwin CM; Wead S; Stockmann C; Healy D; Spigarelli MG; Neely A; Kagan R
Burns; 2014 Mar; 40(2):311-8. PubMed ID: 23876785
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics in critically ill patients.
Varghese JM; Roberts JA; Lipman J
Curr Opin Anaesthesiol; 2010 Aug; 23(4):472-8. PubMed ID: 20489605
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature.
Ortwine JK; Pogue JM; Faris J
J Burn Care Res; 2015; 36(2):e72-84. PubMed ID: 25167375
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL
Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
